FreeCME

Expert Illustrations & Commentaries™: Harnessing the Power of SYK Inhibition to Reduce the Inflammatory Response in Patients Hospitalized With COVID

CME: 1.0

Target Audience

This educational activity is directed toward pulmonologists, infectious disease specialists, critical care clinicians, emergency medicine clinicians, internists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with COVID-19–induced acute respiratory distress syndrome (ARDS).

Program Overview

This Expert Illustrations and Commentaries™ is a video-based program in which 2 experts discuss the etiology and management of COVID-19–related acute respiratory distress syndrome (ARDS). In this activity the faculty focus on the pathophysiology and current and emerging therapeutic strategies for the management of these pulmonary concerns. Their discussion is enriched with the use of video animations to illustrate both the mechanism of COVID-19–related disease and the mechanism of action of emerging therapies. The use of these animated segments helps make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians identify best practices in the diagnosis and management of COVID-19–related ARDS and to improve outcomes for their patients with this disease.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Describe the pathophysiology of COVID-19–induced ARDS
  • Discuss the role of spleen tyrosine kinase (SYK) in the development of COVID-19–induced ARDS
  • Analyze emerging clinical trial evidence regarding the use of SYK-targeted therapy in patients with COVID-19–induced ARDS

Post a comment to this article